Articles tagged "Hepatitis"

2020 American Transplant Congress
IM Naltrexone Post Liver Transplant for Alcoholic Hepatitis Patients to Prevent Relapse
A. Flecha
Transplant Surgery, Montefiore Medical Center, Bronx, NY
*Purpose: The number of patients requiring liver transplants due to Hepatitis C Virus is declining due to the new treatment options, and the growing number…
2020 American Transplant Congress
Outcome of Hepatitis B Virus DNA-Positive Liver Transplantation in Hepatitis B Virus/Hepatitis D Virus Co-Infected Recipient Treated with High Dose Hepatitis B Immune Globulin: A Case Report
M. B. Hammami¹, M. Haris¹, L. Toman¹, N. Danis¹, B. Saberi², E. King³, J. Garonzik-Wang³, B. Philosophe³, A. M. Cameron³, A. Gurakar¹
¹Gastroenterology and Hepatology, Johns Hopkins, Baltimore, MD, ²Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, NY, ³Transplant Surgery, Johns Hopkins, Baltimore, MD
*Purpose: Introduction: While common in Asian countries, liver transplantation (LT) for patients with hepatitis B virus (HBV)/hepatitis D virus (HDV) co-infection is rare in the…
2020 American Transplant Congress
Hepatitis C Antibody Seroconversion after Transplantation of Kidneys from Hepatitis C Infected Donors to Hepatitis C Negative Recipients
U. A. Agbim¹, O. Cseprekal², M. Yazawa¹, M. Talwar¹, V. Balaraman¹, A. Bhalla¹, P. S. Podila³, B. Maliakkal¹, S. Nair¹, J. D. Eason¹, M. Z. Molnar¹
¹James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, ²Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary, ³Faith & Health Division, Methodist Le Bonheur Healthcare, Memphis, TN
*Purpose: We aimed to assess factors associated with hepatitis C virus (HCV) seroconversion among HCV seronegative kidney transplant candidates receiving HCV infected donor kidneys.*Methods: This…
2020 American Transplant Congress
Access to Direct Acting Antiviral Therapy for Recipients of Solid Organs from Hepatitis C Viremic Donors
C. Edmonds, A. Carver, J. DeClercq, L. Choi, M. Peter, R. Forbes, B. Concepcion, K. Schlendorf, R. Perri
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Emerging data supports transplantation of organs from hepatitis C-positive (HCV) donors to expand the donor pool, but access to direct acting antivirals (DAAs) to…
2019 American Transplant Congress
Hepatitis A Hospitalizations among Kidney Transplant Recipients in the United States: A Nationwide Study
W. Cheungpasitporn¹, C. Thongprayoon², P. Ungprasert³, K. Wijarnpreecha⁴, P. T. Kroner⁴
¹Nephrology, University of Mississippi Medical Center, Jackson, MS, ²Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ³Nephrology, University of Mississippi Medical Center, Bangkok, Thailand, ⁴Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL
*Purpose: Hepatitis A illness severity increases in immunosuppressed patients and one of important indicators of hepatitis A illness severity is whether patients require hospitalization. This…
2019 American Transplant Congress
Introduction of Universal Hepatitis E RNA Screening in Deceased Organ Donors – The UK Experience
I. Ushiro-Lumb¹, K. Tettmar¹, I. Johannessen², K. Simpson², I. Hart³, J. Timms⁴, A. Hale⁵, S. Ijaz⁶, R. Tedder⁶, J. Forsythe¹
¹NHS Blood and Transplant, London, United Kingdom, ²Royal Infirmary of Edinburgh, Edinburgh, United Kingdom, ³Royal Liverpool University Hospital, Liverpool, United Kingdom, ⁴University Hospitals Coventry and Warwickshire, Coventry, United Kingdom, ⁵Public Health England, Leeds, United Kingdom, ⁶Public Health England, London, United Kingdom
*Purpose: We aim to describe the strategy and initial results of post-donation, universal screening of deceased organ donors in the UK. HEV RNA is tested…
2019 American Transplant Congress
HOPE in Action: A Multicenter Prospective Study of HIV to HIV Liver Transplantation
C. Durand¹, S. Florman², M. Bowring³, D. Brown¹, B. Haydel², J. Hamilton¹, P. Stock⁴, J. Price⁵, T. Pruett⁶, V. Kirchner⁷, D. Wojciechowksi⁸, N. Turgeon⁹, C. Wolfe¹⁰, V. Stosor¹¹, J. Charette¹¹, A. Cameron³, S. Ottmann³, S. Huprikar¹², D. Segev³
¹Medicine, Johns Hopkins University, Baltimore, MD, ²Surgery, Mount Sinai, New York, NY, ³Surgery, Johns Hopkins University, Baltimore, MD, ⁴Surgery, University of California San Francisco, San Francisco, CA, ⁵Medicine, University of California San Francisco, San Francisco, CA, ⁶Surgery, University of Minnesota, Minneapolis, MN, ⁷Medicine, University of Minnesota, Minneapolis, MN, ⁸Medicine, Mass General Hospital, Boston, MA, ⁹Surgery, Emory University, Atlanta, GA, ¹⁰Medicine, Duke University, Durham, NC, ¹¹Medicine, Northwestern University, Chicago, IL, ¹²Medicine, Mount Sinai, New York, NY
*Purpose: HIV+ liver transplant (LT) candidates face higher mortality and lower access to transplant compared to HIV- counterparts. With the US HOPE Act, HIV+ donor…
2019 American Transplant Congress
Transmission of Infections from Organ Donor to Recipient – German Data
K. Moench, A. Rahmel, A. P. Barreiros
German Foundation for Organtransplantation (DSO), Frankfurt, Germany
*Purpose: In Europe, vigilance monitoring after organ transplant includes Serious Adverse Events (SAE) as well as Serious Adverse Reactions (SAR). All SAE and SAR related…
2019 American Transplant Congress
Liver Transplantation in Acute Hepatic Insufficiency Induced by Imatinib
A. I. David¹, D. N. Alvarenga de Rezende², M. C. Fantauzzi³, T. Di Santi³, N. C. Confuorto³, G. T. Martinho³, P. S. Antunes³
¹GI Surgery/Transplant, Hospital Samaritano de Sao Paulo, Sao Paulo, Brazil, ²GI Surgery/Transplant, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Sao Paulo, Brazil, ³Faculdade de Ciências Médicas da Santa Casa de São Paulo, Sao Paulo, Brazil
*Purpose: Case report of a Woman, pediatrician, 40 yo,with chronic myeloid leukemia using Imatinib who developed Serious Acute Hepatic Failure and needed liver transplant to…
2019 American Transplant Congress
Case Series: Anti-Thymocyte Globulin as a Treatment for Steroid-Refractory Severe Acute Hepatitis in Children
A. L. Peters, A. Miethke, K. Campbell
Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
*Purpose: Pediatric severe acute hepatitis (SAH), when not attributed to acetaminophen toxicity, is commonly hypothesized to be caused by a non-typeable viral infection and/or immune…